Speaker Faculty

The Cancer Vaccine Development Conference will bring together experts from pharmaceutical and biotechnology fields to explore the latest advancements in cancer vaccine development. Discussions will cover the ongoing efforts to accelerate cancer vaccine development through the integration of combination therapies, immunotherapies, and scalable adjuvant manufacturing. The conference will address the importance of enhancing the vaccine’s effectiveness by monitoring immune responses, particularly through genetic and epigenetic modifications. In addition, it will delve into the use of advanced sequencing technologies underscored as a key tool to drive clinical success and improve patient outcomes.